Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to see if Tarceva® (erlotinib) is effective in shrinking
tumors. A high resolution CT scan (CT scanner that can view 3 dimensional images of the
tumor) will be used to measure the tumor before and after treatment with Tarceva®(erlotinib)
. This type of CT scan will measure the tumor by volume and by standard measurement (length
and width). Both methods will be compared to find out whether standard measurement or
measurement by tumor volume is more accurate.